Psychosis-related Physiological and Neuronal Phenotypes in 22q11 Deletion Syndrome
Psychosis-related Physiological and Neuronal Phenotypes in 22q11 Deletion Syndrome
批准号:
10468740
负责人:
Joseph F. Cubells
金额:
$64.84万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-09-01 至 2024-07-31
关键词:
22q11AcousticsAdolescent and Young AdultAffectAttenuatedBiologicalCategoriesCellsCharacteristicsChromosome 22Chromosome ArmClinicalCognitionDNADiGeorge SyndromeDiagnosisDiseaseEvoked PotentialsExhibitsFaceFunctional disorderGene Expression ProfileGenerationsGenesGeneticGenetic DiseasesGlutamatesHeart AbnormalitiesHeritabilityHumanImmuneImpaired cognitionImpairmentIndividualInduced pluripotent stem cell derived neuronsKnowledgeLeadLightLinkLive BirthMeasuresMolecularNeurobehavioral ManifestationsNeuronal DysfunctionNeuronsPatientsPersonsPhenotypePhysiologicalPluripotent Stem CellsPopulationPropertyPsychophysiologyPsychosesReflex actionResearchSchizophreniaSeveritiesSpeedStartle ReactionStimulusSymptomsSynapsesSynaptic TransmissionSyndromeT-LymphocyteTestingTimeTrainingWorkbaseclinical phenotypecognitive functioneffective therapyemerging adultfollow-upgenetic predictorsglutamatergic signalinghigh riskhigh risk populationhuman subjectindexinginduced pluripotent stem cellinterstitialnerve stem cellneuropsychiatrynovelphenotypic biomarkerpredicting responseprepulse inhibitionprocessing speedpsychotic symptomsrelating to nervous systemresponseschizophrenia risk
中文摘要
项目摘要
在这项修订后的提案中,我们计划检查大脑皮质神经元的生理和突触特性。
多能干细胞(IPSC)来源的神经元以及精神分裂症(SCZ)相关
生理表型,收集自22q11缺失综合征(22q11DS)患者。
这种综合征与患精神分裂症的风险增加20-30倍有关。20%-30%
患有22q11DS的患者在成年早期发展为SCZ。声学惊吓反应(ASR)是
这是一种进化上保守的反射,与健康对照组相比,SCZ的某些方面有所不同。
根据表型对非22q11DS高危人群进行的SCZ研究
这些特征(即有前驱症状的特征)表明ASR的潜伏期可以预测
转换为SCZ。失配负波(MMN)是一种对异常或异常反应的诱发电位
“奇怪的”声刺激嵌入在一系列重复的声刺激中。受损的
产生对奇怪刺激的增强反应的是良好复制的MMN
在SCZ中看到异常。我们建议的工作将检查老年人的ASR措施和MMN
有22q11DS的青少年和年轻人(和健康对照组)来检验这一假设
ASR和/或MMN的潜伏期将预测前驱症状的严重程度,并最终
在这个基因定义的高危人群中,转换为SCZ。同时我们也会研究
22q11DS来源的IPSC来源神经元ASR和MMN的潜在细胞机制
患者在ASR中表现出极端的潜伏期惊厥。我们假设这样做
将确定22q11表型影响的潜在细胞机制
缺失(包括SCZ的风险增加)。因此,这项研究将阐明基因是如何
机制改变了与观察到的临床和生理差异相关的细胞特性
在SCZ和SCZ前驱。
英文摘要
Project Summary
In this revised proposal, we plan to examine the physiological and synaptic properties of
pluripotent stem cell (iPSC)-derived neurons, as well as schizophrenia (SCZ)-related
physiological phenotypes, gathered from patients with 22q11 Deletion Syndrome (22q11DS).
The syndrome associates with a 20-30 fold increase in the risk for schizophrenia. 20-30% of
patients with 22q11DS develop SCZ by early adulthood. The acoustic startle response (ASR) is
an evolutionarily conserved reflex, aspects of which differ in SCZ compared to healthy controls.
Prior work on non-22q11DS individuals at high risk for SCZ based on their phenotypic
characteristics (i.e., those with prodromal symptoms) suggest that the latency of ASR predicts
conversion to SCZ. Mismatch negativity (MMN) is an evoked potential in response to unusual or
“oddball” acoustic stimuli imbedded within a train of repetitive acoustic stimuli. Impaired
generation of an enhanced response to the oddball stimuli is the well-replicated MMN
abnormality seen in SCZ. Our proposed work will examine ASR measures and MMN in older
adolescents and young adults with 22q11DS (and healthy controls) to test the hypothesis that
latency of the ASR and/or MMN will predict severity of prodromal symptoms, and ultimately
conversion to SCZ, in this genetically defined high-risk group. Simultaneously we will study
potential cellular mechanisms related to ASR and MMN in iPSC-derived neurons from 22q11DS
patients exhibiting extreme values of latency to startle in the ASR. We hypothesize that doing so
will identify potential cellular mechanisms underlying the phenotypic impact of the 22q11
deletion (including elevated risk for SCZ). This research will thus shed light on how genetic
mechanisms alter cellular properties relevant to clinical and physiological differences observed
in SCZ and the SCZ prodrome.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Psychosis-related Physiological and Neuronal Phenotypes in 22q11 Deletion Syndrome
-
批准号:10670277
-
项目类别:
-
资助金额:$65.58万
-
财政年份:2019
-
负责人:Joseph F. Cubells
-
依托单位:
Psychosis-related Physiological and Neuronal Phenotypes in 22q11 Deletion Syndrome
-
批准号:10238027
-
项目类别:
-
资助金额:$69.37万
-
财政年份:2019
-
负责人:Joseph F. Cubells
-
依托单位:
Psychosis-related Physiological and Neuronal Phenotypes in 22q11 Deletion Syndrome
-
批准号:10005473
-
项目类别:
-
资助金额:$70.91万
-
财政年份:2019
-
负责人:Joseph F. Cubells
-
依托单位:
Translational analysis of functional variation in human dopamine beta?hydroxylase
-
批准号:8298987
-
项目类别:
-
资助金额:$19.17万
-
财政年份:2011
-
负责人:Joseph F. Cubells
-
依托单位:
Translational analysis of functional variation in human dopamine beta?hydroxylase
-
批准号:8191158
-
项目类别:
-
资助金额:$23.04万
-
财政年份:2011
-
负责人:Joseph F. Cubells
-
依托单位:
Genetic Modulators of HPA-Axis Regulation, Stress Sensitivity
-
批准号:8111194
-
项目类别:
-
资助金额:$23.77万
-
财政年份:2010
-
负责人:Joseph F. Cubells
-
依托单位:
Secondary Research Project: Genetics
-
批准号:8119600
-
项目类别:
-
资助金额:$15.39万
-
财政年份:2010
-
负责人:Joseph F. Cubells
-
依托单位:
Genetic Modulators of HPA-Axis Regulation, Stress Sensitivity
-
批准号:7931867
-
项目类别:
-
资助金额:$24.18万
-
财政年份:2009
-
负责人:Joseph F. Cubells
-
依托单位:
Secondary Research Project: Genetics
-
批准号:7892512
-
项目类别:
-
资助金额:$14.42万
-
财政年份:2009
-
负责人:Joseph F. Cubells
-
依托单位:
Pharmacogenetics Core
-
批准号:7648024
-
项目类别:
-
资助金额:$42.42万
-
财政年份:2008
-
负责人:Joseph F. Cubells
-
依托单位:
Secondary Research Project: Genetics
-
批准号:7645105
-
项目类别:
-
资助金额:$14.32万
-
财政年份:2008
-
负责人:Joseph F. Cubells
-
依托单位:
Pharmacogenetics Core
-
批准号:7514102
-
项目类别:
-
资助金额:$29.09万
-
财政年份:2007
-
负责人:Joseph F. Cubells
-
依托单位:
Genetics of plasma dopamine beta-hydroxylase activity in schizophrenia
-
批准号:7559504
-
项目类别:
-
资助金额:$43.04万
-
财政年份:2007
-
负责人:Joseph F. Cubells
-
依托单位:
Genetics of plasma dopamine beta-hydroxylase activity in schizophrenia
-
批准号:7213761
-
项目类别:
-
资助金额:$51.56万
-
财政年份:2007
-
负责人:Joseph F. Cubells
-
依托单位:
Pharmacogenetics Core
-
批准号:6830597
-
项目类别:
-
资助金额:$17.48万
-
财政年份:2004
-
负责人:Joseph F. Cubells
-
依托单位:
Human Genetics of Drug-Abuse Related Phenotypes
-
批准号:6560033
-
项目类别:
-
资助金额:$11.71万
-
财政年份:2003
-
负责人:Joseph F. Cubells
-
依托单位:
Human Genetics of Drug-Abuse Related Phenotypes
-
批准号:6926290
-
项目类别:
-
资助金额:$12.17万
-
财政年份:2003
-
负责人:Joseph F. Cubells
-
依托单位:
Human Genetics of Drug-Abuse Related Phenotypes
-
批准号:7106607
-
项目类别:
-
资助金额:$12.17万
-
财政年份:2003
-
负责人:Joseph F. Cubells
-
依托单位:
Human Genetics of Drug-Abuse Related Phenotypes
-
批准号:7250924
-
项目类别:
-
资助金额:$12.17万
-
财政年份:2003
-
负责人:Joseph F. Cubells
-
依托单位:
Human Genetics of Drug-Abuse Related Phenotypes
-
批准号:6734225
-
项目类别:
-
资助金额:$12.32万
-
财政年份:2003
-
负责人:Joseph F. Cubells
-
依托单位:
海外基金